Latest Articles
Sensei finds Faeth | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Sensei finds Faeth | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: Feb. 19, 2026, 3:47 p.m.
Endometriosis Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com
Endometriosis Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Domain | DelveInsight Barchart.com
Published: Feb. 12, 2026, 9:42 p.m.
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Manila Times
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The Manila Times
Published: Jan. 22, 2026, 6:07 p.m.
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Yahoo Finance
Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight Yahoo Finance
Published: Jan. 22, 2026, 6 p.m.
No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Published: Jan. 12, 2026, 1:11 p.m.
Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations - OncLive
Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations OncLive
Published: Jan. 2, 2026, 1:10 p.m.
Clinical Trial: CBD Dosing Reduces Blood Pressure in Patients With Hypertension - NORML
Clinical Trial: CBD Dosing Reduces Blood Pressure in Patients With Hypertension NORML
Published: Dec. 18, 2025, 1:44 p.m.
Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors - The Manila Times
Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors The Manila Times
Published: Dec. 10, 2025, 12:40 p.m.
Cartherics appoints Dr Ian Nisbet as CEO as the company accelerates toward clinical trials - BiotechDispatch
Cartherics appoints Dr Ian Nisbet as CEO as the company accelerates toward clinical trials BiotechDispatch
Published: Dec. 1, 2025, 11:34 p.m.
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer - University of Miami
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer University of Miami
Published: Nov. 12, 2025, 1:59 p.m.
Link copied to clipboard!